Top 10 cannabis stock news stories of the week

Welcome to the Cannabis Countdown. We will discuss and countdown the top ten marijuana stock news stories for the week of October 28th to November 3rd, 2019. In November 2018, marijuana looked to be the hottest investment since sliced bread. We’ll recap the top news in the world of cannabis so you can keep up with the trends. This includes cannabis stock news from Hexo, MedMen, and Canopy Growth.

The portal gathered and recapped the top 10 cannabis stock news stories from the week of Oct. 28 to Nov. 3, 2019.

10. CFN Media interviews Red White & Bloom CEO, Brad Rogers

Firstly, Brad Rogers, CEO of Super State Operator Red White & Bloom goes deep with Greg Hasty of CannabisFN.

CFN Media, one of the largest financial networks focused on cannabis has just published an interview with the CEO of Red White & Bloom (CSE: RWB – IPO Soon), Brad Rogers.

The video interview took place at the Benzinga Cannabis Capital Conference in Chicago last week.

9. Super Bowl champion, Rob Gronkowski, joins Abacus Health

Gronkowski is ready for CBD ‘Gronk Spike’ market with a new CBDMEDIC commercial business.

Multiple injuries and first-hand experience with the CEO of Abacus Health Products convinced Gronk to join the CBD wave.

8. Canadian cannabis stock news reveals the reason for marijuana storage

The trajectory of cannabis stocks can change dramatically.

With large institutions still reluctant to invest in marijuana, Canadian retail investors continue to dominate the public floats of many marijuana stocks, especially those based in the U.S.

7. MedMen doubles revenue while EBITDA loss triples

After weak fourth-quarter earnings, MedMen changes $250 million in Gotham Green Credit Facility.

MedMen released its fourth-quarter results yesterday after the closing of the bell and the “Apple Store of Weed” disappointed investors once again.

MedMen recorded revenue of $42 million in the fourth quarter, an increase of 104% year on year. However, MedMen’s adjusted EBITDA loss for the full year was more than triple that of 2018.

6. Bay Street profits from the marijuana frenzy before the massacre

The warning signs were there all summer. It wasn’t until the first of September that the day of the settlement of scores arrived.

After markets closed on Sept. 3, Aurora Cannabis tried to sell its 10.5% stake in The Green Organic Dutchman to public investors.

The sector’s original financiers have now moved on to more promising U.S.-based companies, or are completely out of the sector.

5. Hexo Corp reports fourth-quarter earnings in cannabis stocks news

Revenue records of $15.4 million and a loss of $56.7 million have been recorded by Hexo Corp.

The company reported financial results for the fourth quarter of 2019, recognizing net revenue of $15.39 million during the quarter, and recording a total net loss of $56.68 million.

4. Canopy Growth reveals new cannabis drinks and edibles

Canopy has also introduced two THC-infused beverages under its Seth Rogen-supported “House Plant” brand.

Additionally, Canopy Growth has launched its first batch of cannabis drinks and chocolates. Products include psychoactive ginger-ale, CBD-infused cucumber-mint soda water, and cocoa “Bean & Bud” medallions.

3. HEXO to launch Flow Glow CBD

New HEXO licenses allow the sale of edible products, beverages, extracts and cannabis topics.

HEXO Corp and partner JV Molson Coors expect to launch their new Flow Glow CBD drink in December.

2. Cannabis 2.0 flourishing in the U.S. market

Is a diversified Canadian market really cannabis 2.0? Or is it the huge opportunity south of the border?

All Canadian cannabis stock news face headwinds and yet they trade for heavy multiples, as the comparison charts below show.

These prices are unjustified until the real prize in the U.S. market comes into play.

1. Net revenue for Liberty Health rises 379%

Liberty Health sees a net revenue increase in the second quarter to $10.63 million while shares jump 20% in response to stellar gains.

The company reported its earnings this morning in the second-quarter ending on Aug. 31, 2019.

The company saw its consolidated net revenue in the quarter increase 378.88% year on year.

An additional example of a great investment company

The investment company World High Life (NEX: LIFE) is also making big cannabis stock news headlines.

World High Life (WHL) announced its attention to buy the British producer of cannabis oil, Love Hemp for $11.23 million. This is part of its strategy of entering the European market.

WHL also announced that it will place shares worth $6.25 million in the United Kingdom stock exchange.

The company was incorporated on Jan. 30, 2019 as an investment vehicle to identify opportunities and acquisitions in companies to specifically take advantage of the rapidly changing regulatory environment surrounding legal medicinal cannabis.

__

(Featured image by FirmBee via Pixabay)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Hemp.im, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of

the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in SECHAT, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.